跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
dextromethorphan + phenylephrine
首页
药物
dextromethorphan + phenylephrine
dextromethorphan + phenylephrine
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
PHENYLEPHRINE TANNATE, PYRILAMINE TANNATE AND DEXTROMETHORPHAN TANNATE SALTS IN PHARMACEUTICAL COMPOSITIONS
US 2008125453 A1
申请人: TIBER LAB LLC
优先权: 2003
US
2 件公开
Combined herbal and pharmaceutical composition and method
US 10610559 B2
申请人: SYED UWAIS M
优先权: 2018
US
2 件公开
US 10086026 B2
申请人: SYED UWAIS M
优先权: 2016
US
Compound oral solution and preparation method thereof
CN 116832038 A
申请人: SICHUAN FENGCHUN PHARM CO LTD
优先权: 2020
CN
2 件公开
Compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction
US 2007160689 A1
申请人: EVERETT LAB INC
优先权: 2006
US
US 2008014267 A1
申请人: EVERETT LAB INC
优先权: 2006
US
Non-narcotic biphasic release compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction
US 2008014261 A1
申请人: GIORDANO JOHN A
优先权: 2006
US
Compound oral solution containing dextromethorphan hydrobromide and preparation method thereof
CN 109010341 A
申请人: NANJING GRITPHARMA CO LTD
优先权: 2018
CN
Compound dextromethorphan oral solution, preparation method thereof and use thereof
CN 110327339 A
申请人: BEIJING BODA LYUZHOU MEDICINE TECH RESEARCH CO LTD
优先权: 2019
CN
Anti-cold drug suitable for children aged 4-11 years old and preparation method of drug
CN 110302149 A
申请人: BEIJING BODA OASIS MEDICAL TECH RESEARCH CO LTD
优先权: 2019
CN
Compound solid compositions containing phenylephrine bitartrate and aspirin, preparation and application thereof
CN 111714503 A
申请人: BEIJING BODA OASIS MEDICAL TECH RESEARCH CO LTD
优先权: 2020
CN
Liquid composition containing phenylephrine hydrochloride as well as preparation and application thereof
CN 111588694 A
申请人: BEIJING BODA OASIS MEDICAL TECH RESEARCH CO LTD
优先权: 2020
CN
第 1 / 2 页
上一页
下一页
药物
反馈